GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $2.34 million. The enterprise value is $1.99 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 3.66 million shares outstanding. The number of shares has increased by 2,011.78% in one year.
| Current Share Class | 3.66M |
| Shares Outstanding | 3.66M |
| Shares Change (YoY) | +2,011.78% |
| Shares Change (QoQ) | +79.45% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 7.18% |
| Float | 3.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85
| Current Ratio | 0.85 |
| Quick Ratio | 0.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -294.65 |
Financial Efficiency
Return on equity (ROE) is -527.20% and return on invested capital (ROIC) is -204.68%.
| Return on Equity (ROE) | -527.20% |
| Return on Assets (ROA) | -150.30% |
| Return on Invested Capital (ROIC) | -204.68% |
| Return on Capital Employed (ROCE) | 2,713.25% |
| Weighted Average Cost of Capital (WACC) | 4.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.13M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.97% in the last 52 weeks. The beta is 0.77, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -91.97% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 3.70 |
| Relative Strength Index (RSI) | 46.10 |
| Average Volume (20 Days) | 6,017,546 |
Short Selling Information
The latest short interest is 2.17 million, so 59.21% of the outstanding shares have been sold short.
| Short Interest | 2.17M |
| Short Previous Month | 670,479 |
| Short % of Shares Out | 59.21% |
| Short % of Float | 60.17% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.80M |
| Pretax Income | -16.89M |
| Net Income | -16.89M |
| EBITDA | -16.74M |
| EBIT | -16.80M |
| Earnings Per Share (EPS) | -$17.13 |
Full Income StatementBalance Sheet
The company has $3.93 million in cash and $3.59 million in debt, with a net cash position of $341,000 or $0.09 per share.
| Cash & Cash Equivalents | 3.93M |
| Total Debt | 3.59M |
| Net Cash | 341,000 |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | -851,000 |
| Book Value Per Share | -0.34 |
| Working Capital | -761,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.35 million and capital expenditures -$87,000, giving a free cash flow of -$16.44 million.
| Operating Cash Flow | -16.35M |
| Capital Expenditures | -87,000 |
| Depreciation & Amortization | 56,000 |
| Net Borrowing | 3.59M |
| Free Cash Flow | -16.44M |
| FCF Per Share | -$4.49 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
